InvestorsHub Logo
Followers 6
Posts 4111
Boards Moderated 0
Alias Born 12/14/2009

Re: mpreorder post# 33463

Wednesday, 09/13/2017 9:33:09 AM

Wednesday, September 13, 2017 9:33:09 AM

Post# of 108192
Mp, re-read the press release. There was no statement about looking at the data then deciding to termite it. All that was said is the following:

As part of its portfolio refinement, the company has determined it will not pursue further clinical study of ADXS-HER2 at this time, but remains open to ISTs or licensing opportunities.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News